Unknown

Dataset Information

0

Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors.

ABSTRACT: QPT-1 was discovered in a compound library by high-throughput screening and triage for substances with whole-cell antibacterial activity. This totally synthetic compound is an unusual barbituric acid derivative whose activity resides in the (-)-enantiomer. QPT-1 had activity against a broad spectrum of pathogenic, antibiotic-resistant bacteria, was nontoxic to eukaryotic cells, and showed oral efficacy in a murine infection model, all before any medicinal chemistry optimization. Biochemical and genetic characterization showed that the QPT-1 targets the beta subunit of bacterial type II topoisomerases via a mechanism of inhibition distinct from the mechanisms of fluoroquinolones and novobiocin. Given these attributes, this compound represents a promising new class of antibacterial agents. The success of this reverse genomics effort demonstrates the utility of exploring strategies that are alternatives to target-based screens in antibacterial drug discovery.

SUBMITTER: Miller AA 

PROVIDER: S-EPMC2493097 | biostudies-literature | 2008 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

QPT-1 was discovered in a compound library by high-throughput screening and triage for substances with whole-cell antibacterial activity. This totally synthetic compound is an unusual barbituric acid derivative whose activity resides in the (-)-enantiomer. QPT-1 had activity against a broad spectrum of pathogenic, antibiotic-resistant bacteria, was nontoxic to eukaryotic cells, and showed oral efficacy in a murine infection model, all before any medicinal chemistry optimization. Biochemical and  ...[more]

Similar Datasets

Unknown Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics.
| S-EPMC7883873 | biostudies-literature
Unknown Discovery of 4-alkoxy-2-aryl-6,7-dimethoxyquinolines as a new class of topoisomerase I inhibitors endowed with potent in vitro anticancer activity.
| S-EPMC9263945 | biostudies-literature
Unknown Discovery of Indazole Derivatives as a Novel Class of Bacterial Gyrase B Inhibitors.
| S-EPMC4601062 | biostudies-literature
Unknown Discovery of 2-arylquinazoline derivatives as a new class of ASK1 inhibitors.
| S-EPMC5999544 | biostudies-literature
Unknown Reversible Monoacylglycerol Lipase Inhibitors: Discovery of a New Class of Benzylpiperidine Derivatives.
| S-EPMC9150076 | biostudies-literature
Unknown Discovery of novel bacterial topoisomerase I inhibitors by use of in silico docking and in vitro assays.
| S-EPMC5780498 | biostudies-literature
Unknown Small DNA circles as bacterial topoisomerase I inhibitors.
| S-EPMC9064831 | biostudies-literature
Unknown Developments in Non-Intercalating Bacterial Topoisomerase Inhibitors: Allosteric and ATPase Inhibitors of DNA Gyrase and Topoisomerase IV.
| S-EPMC9964621 | biostudies-literature
Unknown Fragment-based discovery of a new class of inhibitors targeting mycobacterial tRNA modification.
| S-EPMC7641325 | biostudies-literature
Unknown Discovery of a new class of triazole based inhibitors of acetyl transferase KAT2A.
| S-EPMC9331200 | biostudies-literature